Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianlong Chen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Research in Food Science|January 8, 2024
Vegetable and fruit freshness detection based on deep features and principal component analysisYue Yuan, Xianlong Chen
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinomaXinyuan Chen, Shuangni Yu, Jie Chen, et al.
British Journal of Cancer|April 17, 2025
Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastasesXianlong Chen, Shanyue Sun, Jiapeng Zhao, et al.
Neuroendocrinology|May 24, 2022
A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine NeoplasmsXianlong Chen, Shengwei Mo, Liju Zong, et al.
Frontiers in Immunology|November 3, 2022
Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinomaXianlong Chen, Heng Ma, Shengwei Mo, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interceptionXinyuan Chen, Shanyue Sun, Shuofeng Li, et al.
Frontiers in Immunology|August 8, 2022
Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinomaXianlong Chen, Heng Ma, Shengwei Mo, et al.
Journal of Bone Oncology|May 6, 2024
Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1Xianlong Chen, Yeyin Zhong, Simiao Wang, et al.
The Journal of Pathology. Clinical Research|January 17, 2022
PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response moleculesYue Zhang, Xianlong Chen, Shengwei Mo, et al.
Neuroendocrinology|December 28, 2021
High Mast Cell Density Predicts a Favorable Prognosis in Patients with Pancreatic Neuroendocrine NeoplasmsShengwei Mo, Liju Zong, Xianlong Chen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Research in Food Science|January 8, 2024
Vegetable and fruit freshness detection based on deep features and principal component analysisYue Yuan, Xianlong Chen
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinomaXinyuan Chen, Shuangni Yu, Jie Chen, et al.
British Journal of Cancer|April 17, 2025
Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastasesXianlong Chen, Shanyue Sun, Jiapeng Zhao, et al.
Neuroendocrinology|May 24, 2022
A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine NeoplasmsXianlong Chen, Shengwei Mo, Liju Zong, et al.
Frontiers in Immunology|November 3, 2022
Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinomaXianlong Chen, Heng Ma, Shengwei Mo, et al.
Journal for Immunotherapy of Cancer|June 23, 2025
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interceptionXinyuan Chen, Shanyue Sun, Shuofeng Li, et al.
Frontiers in Immunology|August 8, 2022
Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinomaXianlong Chen, Heng Ma, Shengwei Mo, et al.
Journal of Bone Oncology|May 6, 2024
Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1Xianlong Chen, Yeyin Zhong, Simiao Wang, et al.
The Journal of Pathology. Clinical Research|January 17, 2022
PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response moleculesYue Zhang, Xianlong Chen, Shengwei Mo, et al.
Neuroendocrinology|December 28, 2021
High Mast Cell Density Predicts a Favorable Prognosis in Patients with Pancreatic Neuroendocrine NeoplasmsShengwei Mo, Liju Zong, Xianlong Chen, et al.
Pageof 3